Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Coherent Announces High-Power Uncooled G10 Pump Laser Modules for Submarine and Terrestrial Applications
-
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
-
Form 8.3 - UK Commercial Property REIT
-
Fixing of Coupon Interest Rate
-
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
-
SOPERIOR FERTILIZER PREPARING OBA SUBMISSION
-
Aya Gold & Silver: Q4-2023 Results and Conference Call on March 28
-
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
-
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
-
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-10
-
MetaWorks Platforms Expands Holdings into Renewable Energy: Company Secures 11% Equity Stake in Fog Dog Energy Solutions Amid AI and Blockchain Energy Surge
-
Enthusiast Gaming Announces Appointment of Thomas Hearne to its Board of Directors
-
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
-
Director/PDMR Shareholding
-
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US
-
HONKARAKENNE’S BOARD OF DIRECTORS’ REPORT, FINANCIAL STATEMENTS, CORPORATE GOVERNANCE STATEMENT AND REMUNERATION REPORT FOR 2023 HAVE BEEN PUBLISHED
-
Net Asset Value(s)
-
ParaZero Announces 2023 Financial Results
-
Carbon Revolution to Present at Webull Corporate Connect Technology Investment Webinar on March 27, 2024
-
Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards
-
AS Pro Kapital Grupp acquired stake in an Italian real estate company
-
Change in Orion Group Executive Management Board: change in Orion's group-level functions
-
FTAI Aviation Ltd. Announces Timing of First Quarter 2024 Earnings and Conference Call
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CUSTODIAN PROPERTY INCOME RE - Ordinary Shares
-
Notification of major shareholding
-
UTStarcom Reports Unaudited Financial Results for Second Half and Full Year 2023
-
Crestline Announces the Appointment of Leah McFarland to Senior Vice President of Revenue Strategy
-
The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share
-
Coherent Introduces a New Circulator Adaptor Enabling Bi-Directional Fiber Connectivity For AI/ML Applications
-
SANUWAVE Announces Record Q4 and FY2023 Revenue
-
Ålandsbanken Abp (Bank of Åland) announces amendments to the terms and conditions of its covered bond due 2024
-
Umicore publishes its 2023 Integrated Annual Report: Driving transformation for the future
-
The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant
-
ASHTON WOODS USA L.L.C. ANNOUNCES QUARTERLY RESULTS CONFERENCE CALL
-
Share repurchase programme
-
Announcement of Drawings
-
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
-
ChampionX Agrees to Acquire RMSpumptools, Expanding Reach in International, Offshore Production Technologies Markets
-
DNA Plc: Decisions of DNA Plc's shareholder on matters belonging to the Annual General Meeting
-
Form 8.3 - Mondi plc
-
Announcement of drawings (CK95) - Nykredit Realkredit A/S
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Form 8.5 (EPT/RI) - Mattioli Woods
-
Form 8.5 (EPT/RI) - Renalytix plc
-
Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Karolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC
-
Sunlands Technology Group Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results
-
Ontex ranked top 10 of Belgian patent applicants

